Check out our most popular compounded medications! Get Started
Dashboard
Formulas

Nitrofurazone 0.2% Topical Solution

FDA-approved generic
Dose form
Topical Solution
Active ingredients
Nitrofurazone
For prescribers
Prescription details
RxThis formula
Dose formSee below
Quantity____
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription detailsOrder form
Controlled substance: e-prescribe (EPCS) from your EHR. Faxed and phoned prescriptions cannot be accepted for this preparation.
Send it from your EHR, or fax to (401) 284-4506. How to e-prescribe this formula
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
To prescribe, you must be a verified prescriber.
To prescribe, you must be in a state where we hold an active out-of-state pharmacy license.
Starting at
Fill my prescription
Fill my prescription
Requires a prescription from your own provider. Bayview is a pharmacy and does not prescribe.
Ships within 1 to 2 business days after pharmacist verification
HSA and FSA eligible
Check if we ship to your state
No prescription yet?

Get a sheet with everything your doctor needs to prescribe this and send it to Bayview.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.

For prescribersSign in for prescription details and order forms.
Compounded preparations are prepared by Bayview pursuant to a prescription for an individual patient. They are not FDA-approved and have not been evaluated by FDA for safety or effectiveness.
Nitrofurazone
Topical Solution
6427079ea6432484ff518f6d
Service area

Can we ship this formula to your state?

Bayview fills prescriptions for patients in Connecticut, Florida, Maine, Massachusetts, New Hampshire, New Jersey, Pennsylvania and Rhode Island. New York patients are served on a limited basis while nonresident pharmacy registration is pending.

Check your state

Available in

Tap a state to check it.

Our current service area

Currently licensed Limited basis, registration pending Not available for this formula Not currently licensed

Select a state on the map or use the checker.

Prepared to a prescriber's order for one patient. Not FDA-approved.

This formulation

This is a compounded topical solution containing nitrofurazone, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.

FDA product listings

These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.

No finished nitrofurazone product of any kind is listed; the directory holds only bulk ingredient records for it.

Storage category and dating

Liquid bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.

Sources

Why prescribers order this

Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.

Nitrofurazone is a nitrofuran antibacterial for use on the skin that a pharmacy may compound when a prescriber orders it.

About this ingredient

Nitrofurazone is a topical antibacterial of the nitrofuran group. It acts by killing bacteria or preventing their growth. In the United States it was sold by prescription as Furacin cream, soluble dressing and topical solution, and as generic ointments and solutions; an archived MedlinePlus page describes its use to treat infected burns and skin infections related to skin grafts. FDA's Drugs@FDA database lists every human nitrofurazone product as discontinued. The only current DailyMed listings are aquarium fish treatments filed as unapproved drugs and bulk powders, one labeled for animal drug compounding. There is therefore no FDA-approved human nitrofurazone product on the market. A prescriber might order nitrofurazone compounded for a patient because no manufactured human product exists. Compounded preparations are not FDA-approved and require a prescription.

Safety and interactions

No current FDA label exists for a human nitrofurazone product, so there is no boxed warning. The archived MedlinePlus page says to tell your prescriber about any past allergic reaction to nitrofurazone or to preservatives or dyes, and to report itching, rash or swelling, the side effects it lists. Some older solution and dressing forms contained polyethylene glycols, which can be absorbed through the skin and build up in people with kidney problems. In long-term feeding studies, the National Toxicology Program found clear evidence that nitrofurazone caused cancer in female rats and female mice. FDA prohibits its extralabel use in food-producing animals. It has not been studied in pregnant women; high oral doses in rabbits slightly increased stillbirths. It is not known whether it passes into breast milk. If the infection does not improve or gets worse, talk to your prescriber or pharmacist.

Nitrofurazone is a nitrofuran antibacterial applied topically; the archived MedlinePlus (USP DI) monograph describes bactericidal or bacteriostatic activity without further mechanistic detail, and no pharmacokinetic data were found in the sources reviewed. Historical labeled use: Furacin cream, soluble dressing and topical solution were prescription products for infected burns, with the cream and dressing also used for skin infections related to skin grafts. Drugs@FDA lists eleven human applications, NDA005795 (Furacin ointment), NDA017343 (Actin-N dressing) and nine ANDAs, all discontinued, all for topical use. No current human indication exists, so any compounded use is not an FDA-approved indication. NTP Technical Report 337 (1988) found clear evidence of carcinogenic activity in female F344/N rats and female B6C3F1 mice, equivocal evidence in male rats and no evidence in male mice in two-year feed studies. 21 CFR 530.41 lists nitrofurazone among drugs prohibited for extralabel use in food-producing animals. Polyethylene glycol bases warrant caution in renal impairment. Monitor for local hypersensitivity, and reassess if the wound does not improve. Nitrofurazone is not listed as a controlled substance in these sources. Dosing is per prescriber.

Sources

Using and storing

How it is used

Wash your hands. Apply the amount on your label to clean, dry skin using the applicator provided or a cotton swab. Let it dry before covering. Use an accurate measuring device if your label gives a volume. Keep it away from the eyes and avoid open flame if the solution contains alcohol. Wash your hands afterward.

Storing it

Topical solutions are aqueous or alcohol based. Under USP <795>, a preserved aqueous solution usually carries a beyond-use date of up to 35 days; an unpreserved one 14 days refrigerated; a nonaqueous solution may carry up to 180 days. Keep the bottle tightly closed at room temperature, away from heat and flame, out of reach of children, and discard after the beyond-use date on your label.

Sources

Prescribing and ordering FAQs

Formula Information

A small arrow pointing down

Drug Interactions

A small arrow pointing down

How Does it Work

A small arrow pointing down

Frequently Asked Questions

A small arrow pointing down

About this compounded preparation

This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.

A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.

Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.
For prescribers

How to e-prescribe this formula

Controlled substance: e-prescribe only (EPCS). Faxed, phoned, and handwritten prescriptions cannot be filled. Rhode Island law (R.I. Gen. Laws § 21-28-3.18) requires Schedule II to V prescriptions to be transmitted electronically.
1

Find Bayview in your EHR's pharmacy directory

Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.

NCPDP4106882NPI1750455143Address3844 Post Rd, Warwick, RI 02886Phone(401) 284-4505Fax(401) 284-4506
2

Enter the formula as a compound

Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.

Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.

3

Copy the prescription details

RxFormula name
Dose formDose form
Quantity________
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription details

Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.

4

Send it

Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.

Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.

Do not use Notes to Pharmacy for the formula. Some EHRs keep that field internal and never transmit it. A prescription that arrives without the formula is delayed while we call your office.

Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.

Nitrofurazone 0.2% Topical Solution
Topical Solution
60 mL
controlled

Apply topically to affected area(s)

Apply to affected area 2-4 times daily.
Four times daily